• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT

SYNTARA LIMITED

3.33% ! 2.9¢
Market Cap $47.33M  !

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Sip & Learn ?
10/11/25 4 1.3K
10/11/25 Last post  newB Comments Created with Sketch.  4  Views Created with Sketch.  1.3K 
SNT 31/10/25 9 2.1K
31/10/25 Last post  NZ Trader Comments Created with Sketch.  9  Views Created with Sketch.  2.1K 
SNT
Vote Like You Own It
29/10/25 0 205
TRENDING NEWS

The Next Big Market Move Is Closer Than You Think

NEWS
10 Nov 2025
29/10/25 Last post  ContangoPhil Comments Created with Sketch.  0  Views Created with Sketch.  205 
SNT 28/10/25 42 9.8K
28/10/25 Last post  NZ Trader Comments Created with Sketch.  42  Views Created with Sketch.  9.8K 
SNT 21/10/25 7 1.0K
21/10/25 Last post  newB Comments Created with Sketch.  7  Views Created with Sketch.  1.0K 
SNT 15/10/25 2 623
15/10/25 Last post  newB Comments Created with Sketch.  2  Views Created with Sketch.  623 
SNT
How are the Experts remunerated ?
03/10/25 23 3.8K
03/10/25 Last post  PepG1 Comments Created with Sketch.  23  Views Created with Sketch.  3.8K 
SNT 02/10/25 0 204
02/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  204 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Shareholder Report and Appendix 4C
28 Oct 08:30
 
Notice of Annual General Meeting/Proxy Form
20 Oct 10:09
 
Investor Presentation HK Ignite Investment Summit
15 Oct 08:43
 
Notification regarding unquoted securities - SNT
02 Oct 16:47
 
Notice under ASX Listing Rule 3.13.1
01 Oct 09:45
 
Positive final Phase 2a amsulostat data webinar presentation
30 Sep 09:05
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.9¢
Change
-0.001(3.33%)
Mkt cap ! $47.33M
Open High Low Value Volume
3.1¢ 3.1¢ 2.9¢ $11.63K 385.5K

Buyers (Bids)

No. Vol. Price($)
3 120197 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 317727 1
View Market Depth
Last trade - 16.10pm 10/11/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.